France· FR:64247885
LOKELMA 10 g, poudre pour suspension buvable
A medicinal product containing cyclosilicate de zirconium sodique, registered in France by ASTRAZENECA AB, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CYCLOSILICATE DE ZIRCONIUM SODIQUE
- Manufacturer
- ASTRAZENECA AB
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009301480993 sachet(s) polytéréphtalate (PET) PEBDL : polyéthylène à basse densité linéaire aluminiumEUR 19.17
- cip13340093014810530 sachet(s) polytéréphtalate (PET) PEBDL : polyéthylène à basse densité linéaire aluminiumEUR 188.98
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cyclosilicate de zirconium sodique in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLOKELMAAstraZeneca AB, Södertälje
- NorwayLokelmaOrifarm AS
- FinlandLokelmaAbacus Medicine A/S
- IcelandLokelmaAstraZeneca AB*
- NetherlandsLokelma 10 g, poeder voor orale suspensieZS Texas Ltd
- BelgiumLokelma 10 gAstraZeneca
- SwedenLokelma 10 g Pulver till oral suspensionAstraZeneca AB
- CanadaLOKELMAASTRAZENECA CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lokelma
- Liechtenstein · Lokelma
- Norway · Lokelma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/53567a15-a5e6-4770-9861-b729025fa229 GET /v1/drugs/53567a15-a5e6-4770-9861-b729025fa229?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64247885",
"date_amm": "2018-03-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1173",
"substance": "CYCLOSILICATE DE ZIRCONIUM SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cyclosilicate de zirconium sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.